TITLE

CLINICAL OBSERVATIONS IN THROMBOEMBOLIC DISEASE TREATED WITH FIBRINOLYSIN

AUTHOR(S)
Moser, Kenneth M.
PUB. DATE
August 1959
SOURCE
Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p319
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Describes experiences in the treatment of venous and arterial thrombotic disease using fibrinolysin. Ability of the anticoagulant drugs to provide a satisfactory degree of protection against the development of thrombosis; Factors determining response to fibrinolysin; Dependency of the therapy upon the particular form of thrombotic disorder involved.
ACCESSION #
16388424

 

Related Articles

  • CLINICAL OBSERVATIONS IN THE TREATMENT OF PHLEBOTHROMBOSIS WITH FIBRINOLYSIN. Carroll, Bruce J. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p308 

    1. Fibrinolysin has been used in 82 patients without any deleterious occurrences. 2. An excellent response with appreciable shortening of hospital stay was obtained in 60 patients. A good response was obtained in 19 patients. Three patients had a poor response which might be attributed to a...

  • THE TREATMENT OF PULMONARY EMBOLISM WITH FIBRINOLYSIN. Sheffer, Albert L.; Israel, Harold L. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p292 

    An attempt has been made to evaluate fibrinolysin in 33 patients treated for pulmonary embolism or related thrombolic diseases. Six cases of pulmonary embolism are presented in detail. The results suggest that fibrinolysin by itself may not be effective in preventing recurrent embolism. However,...

  • TWO CASES OF MASSIVE EDEMA OF THE LEG TREATED WITH FIBRINOLYSIN. Stewart, Charles F. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p299 

    Two eases of acute, severe iliofemoral phlebitis have been presented with remarkable improvement from fibrinolysin treatment in one case and a qualified success in the second. Fibrinolysin is considered to be a most promising drug in the treatment of venous thrombotic disease.

  • CLINICAL EXPERIENCES WITH FIBRINOLYSIN. Roberts, Brooke; Thompson, Stanley // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p302 

    Discusses the clinical and experimental studies on the use of fibrinolysin. Effect of fibrinolysin on blood pressure; Details on the systemic use of fibrinolysin; Therapeutic effectiveness of the drug.

  • TREATMENT OF CHRONIC THROMBOEMBOLISM WITH ARVIN, ORAL FIBRINOLYTICS AND STANDARD ANTICOAGULANTS. Kounis, Nicholas G.; Evans, W. Howel // Vascular Surgery;Mar/Apr1977, Vol. 11 Issue 2, p68 

    In five patients suffering from recurrent deep venous thrombosis and pulmonary embolism, a therapeutic combination was applied including Arvin, Fearnley's regime and standard anticoagulants. In two patients complete remission of the disease seemed to he achieved during the following two years....

  • Management of Anticoagulant and Thrombolytic Agents in Deep Venous Thrombosis. Coon, William W. // Vascular Surgery;Jan/Feb1982, Vol. 16 Issue 1, p1 

    Presents a study on the management of anticoagulant and thrombolytic agents in deep venous thrombosis. Utilization of the heparin agent in treating the disease; Treatment with oral anticoagulants; Use of thrombolytic agents.

  • Primary Effort Thrombosis: Treatment Options in Acute and Chronic Disease--Case Reports. Adams Jr., Carlton Zelliot; Vincent, G. Steven; Vermilion, Blair; Hoover, Eddie L. // Vascular Surgery;Apr1991, Vol. 25 Issue 3, p234 

    Primary axillary-subclavian vein thrombosis (effort thrombosis) is a unique variant of thoracic outlet syndrome that effects young, active adults. The majority of cases have been demonstrated to be secondary to contriction of the axillary-subclavian vein junction between the interval of the...

  • Recent Developments in Antithrombotic Therapy. Wright, I.S. // Annals of Internal Medicine;Oct69, Vol. 71 Issue 4, p823 

    Discusses the developments in treatments for thrombosis. Factors contributing to the confusion on the study of anticoagulants; Information on therapeutic defibrination; Progress in the use of thrombolytic agents; Interactions with other drugs.

  • INTRAVENOUS ADMINISTRATION OF FIBRINOLYSIN: ITS SYSTEMIC TOXICITY AND EFFECT UPON COMPONENTS OF THE COAGULATION MECHANISM. Moser, Kenneth M. // Angiology;Aug1959 Part 2, Vol. 10 Issue 4, p253 

    1. In the doses used, the toxic potential of fibrinolysin is limited primarily to temperature elevation. In the absence of prophylactic medication, a febrile reaction occurred in 44.4 per cent of the patients, and could be correlated only with the presence of extensive thrombotic material. 2....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics